EFPIA - NEWSLETTER

EFPIA Newsletter 01 February 2024

Tackling inequalities: how can Europe beat cancer everywhere?

Tackling inequalities: how can Europe beat cancer everywhere? 31 January 2024

The risk of developing and surviving cancer are shaped by where you live, according to a new report. The report, written by The Swedish Institute for Health Economics (IHE) and commissioned by the EFPIA Oncology Platform, finds deep inequalities in access to prevention and screening, biomarker testing and innovative treatments, and in quality of life for cancer survivors.

How can we close the #CancerCareGap?

News

31 January 2024 Vaccines Europe and EFPIA advocate for a holistic, data centered approach in Europe's fight...

40% of all cancers are preventable and vaccination is a proven preventive measure for both HPV and HBV

31 January 2024 European Health Data Space: key aspects to be considered in the trilogue discussions

EFPIA calls the co-legislators to seize this opportunity to thoroughly examine aspects raised in this paper to provide...

Events

20 FEB 2024

Getting to the heart of the matter: improving cardiovascular health in Europe Virtual event

Join us to be at the forefront of shaping cardiovascular health management in the EU.

Learn more →

07 MAR 2024

Digitally-enabled healthcare: Is our ecosystem on track? Brussels and online

Organised by the EU Health Coalition.

Learn more →

What we are reading

Resistance to lung cancer treatment examined by CANCER-ID 01 February 2024 (IHI)

Labour Plan for £10 Billion Investment in UK Life Sciences 30 January 2024 (Bloomberg)

Why Language Matters in Digital Endpoint Development 11 January 2024 (Karger)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶